Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Mueller

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
American Journal of Hospital Pharmacy|December 15, 1994
Improved extemporaneous formulation of cyclosporine ophthalmic dropsD W Mueller
American Journal of Hospital Pharmacy|March 1, 1992
Opportunities for pharmacists in support groupsD W Mueller
British Journal of Cancer|July 30, 2009
Role of miRNAs in the progression of malignant melanomaD W Mueller, A K Bosserhoff
Physical Review Letters|April 7, 2010
Fully differential molecular-frame measurements for the electron-impact dissociative ionization of H2S Bellm, J Lower, E Weigold, et al.
Journal of Pain and Symptom Management|April 16, 1999
Treatment of painful skin ulcers with topical opioidsR K Twillman, T D Long, T A Cathers, et al.
Radiology|November 1, 1996
Dual-phase helical CT of the liver: effects of bolus tracking and different volumes of contrast materialL Kopka, J Rodenwaldt, U Fischer, et al.
ESMO Open|September 24, 2023
A soluble LAG-3 protein (eftilagimod alpha) and an anti-PD-L1 antibody (avelumab) tested in a phase I trial: a new combination in immuno-oncologyS-E Al-Batran, D W Mueller, M-R Rafiyan, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
American Journal of Hospital Pharmacy|December 15, 1994
Improved extemporaneous formulation of cyclosporine ophthalmic dropsD W Mueller
American Journal of Hospital Pharmacy|March 1, 1992
Opportunities for pharmacists in support groupsD W Mueller
British Journal of Cancer|July 30, 2009
Role of miRNAs in the progression of malignant melanomaD W Mueller, A K Bosserhoff
Physical Review Letters|April 7, 2010
Fully differential molecular-frame measurements for the electron-impact dissociative ionization of H2S Bellm, J Lower, E Weigold, et al.
Journal of Pain and Symptom Management|April 16, 1999
Treatment of painful skin ulcers with topical opioidsR K Twillman, T D Long, T A Cathers, et al.
Radiology|November 1, 1996
Dual-phase helical CT of the liver: effects of bolus tracking and different volumes of contrast materialL Kopka, J Rodenwaldt, U Fischer, et al.
ESMO Open|September 24, 2023
A soluble LAG-3 protein (eftilagimod alpha) and an anti-PD-L1 antibody (avelumab) tested in a phase I trial: a new combination in immuno-oncologyS-E Al-Batran, D W Mueller, M-R Rafiyan, et al.
Pageof 1